Obstacles & Opportunities for Bioscience Markets

By Nigel G. Skinner MBA, Ph.D.

Published: August, 2003

100+ Pages - 14 Exhibits - 14 Companies Profiled 

Multiplexed assay technologies make up 25% of the total microarrays market-approaching $1.5 billion-and is projected to grow 50% annually over the next 5 years.

This is the only publication focused solely on the increasing commercial interest in multiplexed assay technologies. This Report is essential reading for those decision-makers in the pharmaceutical, biotechnology, and clinical diagnostic industries. 

Multiplexed assays are an important prevailing technology, specifically in the pharmacogenomics arena for drug discovery and clinical diagnostics purposes. As the pharmaceutical industry evolves its business model in accordance with the development of drugs for stratified disease markets, significant growth is anticipated for personalized medicine. The ability to align drug development with these market segments will be critically dependent on emerging SNP-genotyping and protein profiling practices. The concept of such profiling requires the assay of multiple RNA strands and proteins. Ideally, such assays should be conducted within the same sample, in order to reduce costs as well as error. Old school microarrays are less well suited to meet these demands, which has spurred the development of assays capable of such high density multiplexing.  

D&MD's High Density Multiplexed Assays Market Analysis Report identifies both the technological and strategic reasons in support of high density multiplexed assay technologies becoming a major player in disease and patient stratification over the next five years, especially in major areas such as cancer.  

This Report Will Help You: 

Determine the competitive advantage of high density multiplexed assay technologies over their microarray counterparts through a comprehensive breakdown of the capabilities and limitations of both.

Discover the commercial viability of high density multiplexed assay technologies via a thorough analysis of their widespread applications.

Pinpoint the full market potential of multiplexed assay technologies with an examination of the projected applicatory impact through 2008.

Gain insight into the business strategies of key industry players through in-depth analyses of their technologies, including strengths and weaknesses, product pipelines, alliances, and more.

Learn about patenting multiplexed technologies with an assessment of the patent landscape, including current patents and their holders.

Publisher: Drug and Market Development 

To order go to this URL: http://www.bioportfolio.com/cgi-bin/acatalog/DMD_2003.html#a44